Btai stock price target
Web1 day ago · Currently, the analyst consensus on Bioxcel Therapeutics is a Moderate Buy with an average price target of $49.33. See Insiders’ Hot Stocks on TipRanks >> The … WebApr 6, 2024 · The price target raised to $80 per share is four times as large as the last closing price. BXCL501, the treatment identified as Igalmi after its FDA approval, is …
Btai stock price target
Did you know?
WebApr 12, 2024 · The average twelve-month price prediction for Carnival Co. & is $11.58 with a high price target of $18.00 and a low price target of $7.00. Do Wall Street analysts like Carnival Co. & more than its competitors? Analysts like Carnival Co. & less than other Consumer Discretionary companies. WebPrice To Free Cash Flow is a widely used stock evaluation measure. Find the latest Price To Free Cash Flow for BioXcel Therapeutics (BTAI)
WebMar 10, 2024 · BTAI Price Target For more insight on analysts targets of BTAI, see our BTAI price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page. Average Price Target $92.55 Average Broker Recommendation 1.3 (Strong Buy) BTAI Stock Price Chart Interactive … WebApr 10, 2024 · Two investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $50.00. BioXCel Therapeutics (NASDAQ:BTAI) A Hot Buy That Confuses Analysts
WebApr 11, 2024 · BioXcel Therapeutics, Inc. ( NASDAQ:BTAI – Get Rating) Director Krishnan Nandabalan sold 60,000 shares of BioXcel Therapeutics stock in a transaction that occurred on Thursday, April 6th. The... WebApr 12, 2024 · Shares of BTAI stock opened at $17.35 on Wednesday. BioXcel Therapeutics, Inc. has a one year low of $8.80 and a one year high of $34.13. ... Finally, …
WebBTAI has a higher average analyst price target than 2939.86% of stocks in the small market cap category. In the context of stocks in the small market cap category, BIOXCEL …
WebThe analyst firm set a price target for 66.00 expecting BTAI to rise to within 12 months (a possible 282.17% upside). 16 analyst firms have reported ratings in the last year. coach maverick bautista heightWebMar 29, 2024 · BTAI Stock Price Targets and Analyst Ratings BioXcel Therapeutics Inc. Stock NASDAQ: BTAI Open Broker Account NASDAQ Stock Exchange > Healthcare > … cal hr benefits formsWebApr 6, 2024 · According to 16 analysts, the average rating for BTAI stock is "Buy." The 12-month stock price forecast is $54.52, which is an increase of 215.51% from the latest … calhr benefits 2022WebBTAI U.S.: Nasdaq BioXcel Therapeutics Inc. Watch list Create BTAI Alert After Hours Last Updated: Apr 3, 2024 4:49 p.m. EDT Delayed quote $ 19.10 0.00 0.00% After Hours … coach mavisWebApr 10, 2024 · A number of equities research analysts have recently weighed in on BTAI shares. HC Wainwright lowered their price target on BioXcel Therapeutics from $79.00 to $66.00 and set a “buy” rating... coach mavis loafer- womenWeb1 day ago · Currently, the analyst consensus on Bioxcel Therapeutics is a Moderate Buy with an average price target of $49.33. See Insiders’ Hot Stocks on TipRanks >> The company has a one-year high of... calhr benefits manualWebFind real-time BTAI - BioXcel Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. calhr benefits forms